PR
Media
-
HEM Pharma "Secured the world's largest data on the microbiome, recognized ..2024.11.22 -
HEM Pharma, 3Q sales increase by 300.5%2024.11.15 -
HEM Pharma KOSDAQ market listing ceremony2024.11.05 -
Successfully entered KOSDAQ! ‘HEM Pharma’2024.11.05 -
HEM Pharma, general subscription competition rate 672 to 1... listed on KOSDAQ ..2024.10.25 -
HEM Pharma confirms public offering price of 23,000 won... Demand forecast comp..2024.10.22 -
[Video] 'HEM Pharma' preparing for listing on KOSDAQ..."Microbiome game ch..2024.10.17 -
HEM Pharma listed on KOSDAQ in November... “We will lead the microbiome field”2024.10.17 -
HEM Pharma begins full-fledged KOSDAQ listing...submits stock report2024.07.08 -
HEM Pharma Approves Preliminary Review of KOSDAQ Listing...Promoting IPO Full-Sc..2024.06.11 -
Amway signs joint research agreement with HEM Pharma2024.02.29 -
HEM Pharma promotes ‘Profitable Growth’ in 20242024.01.05
- Pohang
-
Address. 102, Business incubator center, Handong Global University, 558, Handong-ro, Heunghae-eup, Buk-gu, Pohang-si, Gyeongsangbuk-do, Republic of Korea
- Gwanggyo
- Address. 404, Ace Gwanggyo Tower 3, 77, Changnyong-daero 256-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
(C) 2022.HEM Pharma Inc. All rights reserved.